CT或MRI鉴别肾细胞癌胰腺转移与胰腺神经内分泌肿瘤
回顾性纳入经活检证实的肾细胞癌胰腺转移(102例)或胰腺神经内分泌肿瘤(32例)患者,评估CT/MRI特征。胰腺神经内分泌肿瘤多为单发、位于胰体尾、均匀强化,肾细胞癌胰腺转移多为多发、位于近端胰腺、不均匀强化。
要点
- 胰腺神经内分泌肿瘤多为单发(88% vs 63%,p=0.008),肾细胞癌胰腺转移多为多发。
- 胰腺神经内分泌肿瘤多位于胰体尾(81% vs 57%,p=0.01),肾细胞癌胰腺转移多位于近端胰腺。
- 胰腺神经内分泌肿瘤多均匀强化(64-79% vs 39-49%,p<0.01-0.03),肾细胞癌胰腺转移多不均匀强化。
核心结论
- 胰腺神经内分泌肿瘤通常单发、位于远端胰腺、均匀强化,而肾细胞癌胰腺转移常多发、位于近端胰腺、不均匀强化。
研究设计与样本
- 回顾性研究纳入经活检证实的肾细胞癌胰腺转移(n=102)或胰腺神经内分泌肿瘤(n=32)患者,共134例(90例男性)、265个病灶(229个肾细胞癌胰腺转移、36个胰腺神经内分泌肿瘤);95例由两位放射科医生独立判读评估观察者间一致性(Cohen kappa),分歧经共识解决,其余39例由另外两位放射科医生共识判读;参考标准为活检病理。
关键影像表现/征象
- 胰腺神经内分泌肿瘤较肾细胞癌胰腺转移更常见为单发病灶(88% vs 63%,p=0.008)。
- 胰腺神经内分泌肿瘤体积较肾细胞癌胰腺转移小(14 mm vs 23 mm,p=0.042)。
- 胰腺神经内分泌肿瘤较肾细胞癌胰腺转移更常见位于胰体尾(81% vs 57%,p=0.01)。
- 胰腺神经内分泌肿瘤较肾细胞癌胰腺转移更常见均匀强化(64-79% vs 39-49%,p<0.01-0.03)。
- 胰腺神经内分泌肿瘤较肾细胞癌胰腺转移T1低信号更少(80% vs 99%,p=0.002),DWI高信号更多(71% vs 58%,p<0.001)。
诊断标准与关键数值
- 肾细胞癌胰腺转移与胰腺神经内分泌肿瘤患者年龄比较:胰腺神经内分泌肿瘤患者显著更年轻(62 ± 12岁 vs 67 ± 9岁,p=0.013)。
- CT/MRI特征观察者间一致性优秀(k=0.86-1.00)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine whether renal cell carcinoma metastases (RCC-Mets) to the pancreas can be differentiated from pancreatic neuroendocrine tumors (PNETs) in patients with RCC on CT or MRI at presentation.
METHODS: This retrospective study included patients with biopsy-proven RCC-Mets (n = 102) or PNETs (n = 32) at diagnosis or after nephrectomy for RCC. Inter-observer agreement (Cohen kappa) was assessed in 95 patients with independent reads by two radiologists, with discrepancies resolved by consensus for final analysis. The remaining 39 cases underwent consensus reads by two different radiologists for final analysis. The CT/MRI images were reviewed for number, size, regional distribution, parenchymal location (exophytic or intrapancreatic), contrast-enhancement, and enhancement pattern of pancreatic lesions in the available phases. Statistical tests were conducted using two sample t-tests and Pearson's chi-squared test for numeric and categorical variables respectively.
RESULTS: The study group comprised of 134 patients (90 males) with 265 lesions (229 RCC-Mets and 36 PNETs). Patients with PNETs were significantly younger (62 ± 12 years vs. 67 ± 9 years, p = 0.013). Inter-observer agreement for CT/MRI features was excellent across multiple imaging variables (k = 0.86-1.00). Most PNETs were single lesions (88 vs. 63%, p = 0.008), smaller in size (14 mm vs. 23 mm, p = 0.042), more common in the body and tail (81 vs. 57%, p = 0.01), showed homogeneous contrast enhancement (64-79% vs. 39-49%, p < 0.01-0.03), less T1-hypointense (80 vs. 99%, p = 0.002) and more DWI hyperintense (71 vs. 58%, p < 0.001) compared to RCC-Mets.
CONCLUSION: PNETs are typically single, occur in distal pancreas, and enhance homogeneously compared to RCC-Mets which are often multiple, occur in the proximal pancreas, and enhance heterogeneously.
引用
- Nduwimana MJ, Colak C, Bilgin C, et al. Differentiation between renal cell carcinoma metastases to the pancreas and pancreatic neuroendocrine tumors in patients with renal cell carcinoma on CT or MRI. Abdom Radiol (NY). 2025. PMID: 39775027. doi:10.1007/s00261-024-04787-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。